For about ten years we have annually arranged Biotech Umeå Investment Day, as a part of Västerbottensdagarna på Grand. Its a day full of partnering between life science startups from the Västerbotten region and international investors. Each partnering session is 25 minutes.

Around 30 investors and 30 entrepreneurs usually participate in Biotech Umeå Investment Day. The day ends with the Västerbotten buffet at Grand Hotels Veranda.

Biotech Umeå Investment Day, 30 January 2020, Grand Hotel, Stockholm – register here

Price: 1 000 SEK (including lunch and Västerbottens buffet included)
Venue: Grand Hôtel, Södra Blasieholmshamnen 8, Stockholm
Time: 8.30–21.00
Last date to register: 15 January 2020

If you have any questions, please contact Pia Keyser,, 073-620 51 61.

Registered companies

At present, the following companies have registered to participate. More non-confidential information about the companies will be presented at this page during December, 2019. In the middle of January you will receive a link to select what companies you would like to meet during the partnering sessions.

Acne Project 
Acne vulgaris affects more than 80 percent of people at some point in their life and frequently continues into adulthood. Recent data suggest that there are about 700 million people living with acne around the world. This case focuses on a novel approach to fighting acne without the hazards of antibiotic resistance development.

Brain Stimulation
Brain Stimulation RehAtt® is a new concept for stroke-rehabilitation. A unique, effective rehabilitation product that combines neuroscience and cutting-edge technology to create an enriched, motivating training environment that stimulates brain plasticity and improves attention function by strengthening neuronal traffic. Proven effective even years after the stroke.

Project G4 stab drugs

Hiloprobe AB has developed a superior method of diagnosing and prognosing patients with colorectal cancer after surgery. Their innovative clinical tool – the ColoNode is far more accurate than current standard procedures, opening up the possibility of personalized medicine within the colorectal cancer field.

Are developing safe and resistance-breaking molecules that target an enzyme essential for nerve signaling in mosquitoes via a new mode of action. In contrast to current insecticides, we have designed our molecules to specifically target mosquitoes, without affecting other organisms.

Instrube Health AB
Has designed an app – Memotus – tailor made for caregivers to communicate with patients in a safe, easy, fast and legal way. Texts, pictures, videos and documents are sent safely. Identification is done via BankID.

Lipum develops a biological pharmaceutical for a novel mechanism of action in the treatment of chronic inflammations. Essentially, the drug will be a monoclonal antibody directed towards the protein bile salt-stimulated lipase, BSSL. One indication is as an orphan drug for the more severe forms of Juvenile Idiopathic Arthritis (JIA), providing patients with an effective treatment alternative having less adverse effects than the drugs used today.

MetaCuRum Biotech
Aim to develop a novel therapeutic for treatment of aggressive prostate cancer. The treatment is intended to improve the quality of life and extend the life expectancy in patients by preventing the formation of metastases. The approach is an antibody that is expected to have fewer side-effects than current treatment options for this indication.

Nordic Health Innovation
With the help of technology, we contribute to more accessible health care for those who need it most. We live by the motto “Empowering the patient”, which means that we want to put the patient in the driver’s seat when it comes to their own health and information that is collected about the individual, for example measurement data from health searches.

Omnio AB, is a biotechnical research and development company with the aim to develop pro-inflammatory protein based drug candidates based on the plasma protein plasminogen. Plasminogen occurs naturally in sufficient levels in the circulation of healthy people, and can thus be derived through blood plasma fractionation procedures, such as the Cohn Process or ProMetic’s PPPSTM process.

Pro Test Diagnostics
Pro Test Diagnostics is developing a routine test to monitor and detect illegal use of one’s own stored blood to enhance performance in elite athletes. The ABT™-test can expose athletes who have used blood doping and the result is not affected by the athlete’s training intensity, the use of high-altitude training or the use of low oxygen tents.

Quretech Bio
Quretech Bio develops innovative antibiotics by stopping bacterial virulence with a first-in-class active substance. The approach is not to kill bacteria, but make them harmless – thus complementing existing treatments and making established antibiotic drugs more effective without causing resistance.